Categories

Volume 4 Issue 1 (January - February, 2016)

Original Articles

Evaluation of metabolic complications associated with chronic kidney disease
Amit Varshney

Background: Chronic kidney disease is a precursor to end-stage kidney disease and is associated with an increased risk of death. The present study assessed metabolic complications associated with chronic kidney disease. Materials & Methods: The present study was conducted on 78 patients of CKD of both genders. General physical examination was done. Blood sample was collected in a dry disposable syringe. The blood sample was centrifuged at 3000 rpm for 10 minutes for the separation of serum and plasma respectively for the estimation of calcium, phosphate, bicarbonate, potassium, urea etc. Results: Out of 78 patients, there were 48 male and 30 females. Out of 78 patients, fatigue was seen in 57 patients, muscle pain in 58, numbness in 52, bone pain in 42 and vomiting in 47. CKD1 was seen in 3, CKD 2 in 3, CKD 3A in 4, CKD 3A in 4, CKD 3B in 16, CKD 4 in 22 and CKD 5 in 30. Hyperkalemia was seen in 13, hypocalcemia in 21, hyperurecemia in 20, metabolic acidosis in 15, hyperphosphatemia in 10 patients. The difference was non- significant (P> 0.05). Conclusion: Authors found that metabolic complications are common in patients with CKD. Hence authors recommend screening for all the metabolic complication from stage 3A onwards. Key words: Chronic kidney disease, Hyperkalemia, metabolic complication.

 
Html View | Download PDF | Current Issue